Inventor · disambiguated record
Seung Yong Seong
Also filed as: SEONG SEUNG YONG
10 granted patents·13 pending applications·5 citations·filing 2009–2024
80Inventor score
Top patents by PatentIndex Score
23 records- 0178US10342807B2Pharmaceutical composition for prevention, treatment or delay of Alzheimer's disease or dementia containing G protein-coupled receptor 19 agent as active ingredientSEOUL NAT UNIV R&DB FOUNDATION·Filed 2018·Granted Jul 9, 2019·1 cites·6 claims
- 0273US10071107B2Pharmaceutical composition for prevention, treatment or delay of Alzheimer's disease or dementia containing G protein-coupled receptor 19 agent as active ingredientSEOUL NAT UNIV R&DB FOUNDATION·Filed 2016·Granted Sep 11, 2018·1 cites·6 claims
- 0368US11998617B2Gene and cell therapy using cell fusion technologyCURAMYS INC·Filed 2021·Granted Jun 4, 2024·0 cites·6 claims
- 0466US9272047B2Use of biological surfactant as anti-inflammatory agent and tissue preservative solutionSEONG SEUNG-YONG·Filed 2009·Granted Mar 1, 2016·3 cites·3 claims
- 0562US11850288B2Gene and cell therapy using cell fusion technologyCURAMYS INC·Filed 2020·Granted Dec 26, 2023·0 cites·7 claims
- 0661US2025084170A1Bispecific humanized single domain antibody to pd-l1 and cd47, and use thereofSHAPERON INC·Filed 2024·Application pending·0 cites
- 0759US2025099487A1Composition for preventing or treating pulmonary fibrosis, comprising taurodeoxycholic acid or pharmaceutically acceptable salt thereof as active ingredientSHAPERON INC·Filed 2024·Application pending·0 cites
- 0857US11077207B2Gene and cell therapy using cell fusion technologyCURAMYS INC·Filed 2018·Granted Aug 3, 2021·0 cites·6 claims
- 0953US2023366875A1Gpcr19-p2xn receptor complex and use thereofSEOUL NAT UNIV R&DB FOUNDATION·Filed 2021·Application pending·0 cites
- 1052US2025134909A1Gel composition for prevention or treatment of atopic dermatitisSHAPERON INC·Filed 2022·Application pending·0 cites
- 1152US2025134910A1Composition for treating coronavirus disease 2019 (covid-19) containing taurodeoxycholic acid or pharmaceutically acceptable salt thereof and antiviral agent as active ingredientsSHAPERON INC·Filed 2022·Application pending·0 cites
- 1252US2023331766A1Method for mass-producing sodium taurodeoxycholateSEOUL NAT UNIV R&DB FOUNDATION·Filed 2021·Application pending·0 cites
- 1351US2025000877A1Composition containing taurodeoxycholic acid or pharmaceutically acceptable salt thereof as active ingredient for preventing or treating viral infectious diseasesSHAPERON INC·Filed 2022·Application pending·0 cites
- 1449US2024391948A1Novel compound that inhibits tnf-alpha generation and inflammasome activity and preparation method thereforSHAPERON INC·Filed 2022·Application pending·0 cites
- 1549US2025262225A1Composition for treatment of covid-19 comprising taurodeoxycholic acid or pharmaceutically acceptable salt thereof as active ingredientSHAPERON INC·Filed 2022·Application pending·0 cites
- 1648US9855283B2Composition comprising GPCR19 agonist as an active ingredient for preventing or treating allergic dermatitisSHAPERON INC·Filed 2017·Granted Jan 2, 2018·0 cites·11 claims
- 1748US2024228670A9Bispecific single domain antibody to pd-l1 and cd47 and use thereofSHAPERON INC·Filed 2022·Application pending·0 cites
- 1847US2024228622A9Single domain antibody against pd-l1 and use thereofSHAPERON INC·Filed 2022·Application pending·0 cites
- 1947US2024228613A9Single domain antibody against cd47 and use thereofSHAPERON INC·Filed 2022·Application pending·0 cites
- 2045US10821127B2Composition for inhibiting myeloid-derived suppressor cells comprising decitabine or its pharmaceutically acceptable salt as active ingredientSNU R&DB FOUNDATION·Filed 2016·Granted Nov 3, 2020·0 cites·6 claims
- 2144US9629854B2Composition comprising GPCR19 agonist as an active ingredient for preventing or treating allergic dermatitisSEOUL TECHNO HOLDINGS INC·Filed 2014·Granted Apr 25, 2017·0 cites·8 claims
- 2241US9718860B2Complex of a protein comprising zinc oxide-binding peptides and zinc oxide nanoparticles, and use thereofCHO NAM-HYUK·Filed 2010·Granted Aug 1, 2017·0 cites·6 claims
- 2340US2021386761A1Composition for preventing or treating inflammatory bowel disease, containing, as active ingredient, taurodeoxycholic acid or pharmaceutically acceptable salt thereofSHAPERON INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seung Yong Seong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →